ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2315

Association of Rheumatic Autoimmune Disease, Including Rheumatoid Arthritis, with Post-Traumatic Stress Disorder but Not Traumatic Brain Injury in Veterans

Biji Kurien 1, Calin Prodan 2 and Robert Scofield1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Department of Neurology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: auto-immunity and environmental factors, autoantibodies, Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Autoimmune diseases, including rheumatoid arthritis (RA) and systemic lupus erythematosus, are 2- to 3-fold more common among those with post-traumatic stress disorder (PTSD) than among matched controls.  In US Armed Service personnel, PTSD is more prevalent among individuals with mild traumatic brain injury (TBI).  For both PTSD and TBI there are immune changes that might predispose to autoimmune disease.  We undertook this study in US veterans to investigate potential differences in risk of autoimmune rheumatic illness for TBI patients with versus PTSD those without PTSD.

Methods: We studied a cohort of 229 subjects (137 with PTSD)  followed in a US Department of Veterans Affairs TBI clinic.  Diagnoses were gathered from the electronic medical record.  Clinical diagnosis of a rheumatic autoimmune disease was confirmed by chart review.  Each subject with RA was evaluated for the 2010 ACR/EULAR RA Classification Criteria. We determined anti-CCP and rheumatoid factor by ELISA, anti-ENA by BioPlex and ANA by indirect immnofluorescence in a randomly selected subgroup of 40 veterans with TBI (20 with PTSD and 20 without PTSD), and without a prior diagnosis of RA, SLE, APL, or myositis.

Results: We found 11 of 137 (8%) TBI/PTSD subjects had RA.  Each of these 11 met the 2010 ACR/EULAR criteria.  Meanwhile, only 2 of 92 (2.1%) of those with TBI without PTSD had RA.  Other rheumatic autoimmune disease in the PTSD/TBI group included polymyositis (3), SLE (1), undifferentiated connective tissue disease (1), and primary APL (1).  Thus, a total of 17/137 (12.5%) in the PTSD/TBI group had a rheumatic autoimmune disease.  Among those with only TBI, there were only 4/92 (4.3%) patients with a rheumatic autoimmune disease. This difference (17/137 versus 4/92) was statistically significant (p=0.02, Fisher’s exact test).  In the subgroup with serology, 6/20 sera from PTSD/TBI were ANA positive, while only 1/20 from TBI alone was ANA positive. Concerning anti-ENA, among PTSD/TBI subjects 1 had anti-Ro/SSA, one had anti-RNP and one had anti-RNP and anti-dsDNA.  No TBI alone subjects had anti-ENA. Low positive RF was common but increased among those in the PTSD/TBI subgroup as compared to TBI alone (16/20 versus 10/20, p=0.04, Fisher’s exact test).

Conclusion: There is an increased prevalence of autoimmune rheumatic disease, in particular rheumatoid arthritis, and positive rheumatic autoantibodies in TBI subjects with PTSD compared to those without PTSD.  We conclude that TBI and autoimmunity are not associated, while autoimmunity – both clinically manifest and silent – is associated with PTSD.  Studies investigating causality and mechanism are indicated in this at-risk population.


Disclosure: B. Kurien, None; C. Prodan, None; R. Scofield, None.

To cite this abstract in AMA style:

Kurien B, Prodan C, Scofield R. Association of Rheumatic Autoimmune Disease, Including Rheumatoid Arthritis, with Post-Traumatic Stress Disorder but Not Traumatic Brain Injury in Veterans [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/association-of-rheumatic-autoimmune-disease-including-rheumatoid-arthritis-with-post-traumatic-stress-disorder-but-not-traumatic-brain-injury-in-veterans/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-rheumatic-autoimmune-disease-including-rheumatoid-arthritis-with-post-traumatic-stress-disorder-but-not-traumatic-brain-injury-in-veterans/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology